Compare VALN & OLPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VALN | OLPX |
|---|---|---|
| Founded | 2012 | 2014 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 820.0M | 941.2M |
| IPO Year | 2021 | 2021 |
| Metric | VALN | OLPX |
|---|---|---|
| Price | $9.72 | $1.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $15.75 | $1.81 |
| AVG Volume (30 Days) | 25.2K | ★ 1.4M |
| Earning Date | 11-20-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $211,089,992.00 | ★ $418,582,000.00 |
| Revenue This Year | $3.64 | $1.84 |
| Revenue Next Year | $12.23 | $2.46 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 13.48 | N/A |
| 52 Week Low | $4.20 | $0.99 |
| 52 Week High | $12.25 | $1.80 |
| Indicator | VALN | OLPX |
|---|---|---|
| Relative Strength Index (RSI) | 65.65 | 51.28 |
| Support Level | $8.77 | $1.34 |
| Resistance Level | $8.98 | $1.46 |
| Average True Range (ATR) | 0.35 | 0.09 |
| MACD | 0.14 | -0.01 |
| Stochastic Oscillator | 91.54 | 27.91 |
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
Olaplex Holdings Inc is a science-enabled, technology-driven beauty company. It offers science-backed solutions that improve hair health. It identifies the majority of consumers' relevant haircare concerns in collaboration with the community of professional hairstylists and consumers and strives to address them through its proprietary technology and innovation capabilities. It offers products through an omnichannel platform that serves professional, specialty retail, and DTC channels. The company derives its revenue through the sale of its hair care products. The company generates the majority of revenue from Professional sales channels followed by Specialty Retail and then DTC. Geographically the company generates the majority of its revenue from the International market.